Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  C CARDIOVASCULAR SYSTEM
    C10 LIPID MODIFYING AGENTS
      C10A LIPID MODIFYING AGENTS, PLAIN
        C10AB Fibrates
          C10AB12 Pemafibrate
            D10711  Pemafibrate (JAN) <JP>

Therapeutic category of drugs in Japan [BR:br08301]
  2  Agents affecting individual organs
    21  Cardiovascular agents
      218  Hyperlipidemia agents
        2183  Clofibrates
          D10711  Pemafibrate (JAN)

Drug groups [BR:br08330]
  Hypolipidemic agent
    DG01946  Hypolipidemic agent
      DG01733  PPAR alpha agonist
        DG01547  Fibrate
          D10711  Pemafibrate
  Metabolizing enzyme substrate
    DG02918  CYP2C8 substrate
      D10711  Pemafibrate
    DG01642  CYP2C9 substrate
      D10711  Pemafibrate
    DG01633  CYP3A/CYP3A4 substrate
      D10711  Pemafibrate
  Transporter substrate
    DG02856  SLCO1B1 substrate
      D10711  Pemafibrate
    DG02932  SLCO1B3 substrate
      D10711  Pemafibrate

Drug classes [BR:br08332]
  Cardiovascular agent
    DG01946  Hypolipidemic agent
      D10711  Pemafibrate

Target-based classification of drugs [BR:br08310]
  Nuclear receptors
    Thyroid hormone like receptors
      Peroxisome proliferator-activated receptor (PPAR)
        NR1C1 (PPARA) [HSA:5465] [KO:K07294]
          D10711  Pemafibrate (JAN) <JP>

New drug approvals in Japan [br08318.html]
  D10711

New drug approvals in the USA, Europe and Japan [br08328.html]
  D10711

Drug metabolizing enzymes and transporters [br08309.html]
  D10711